Volume 25, Number 7—July 2019
Research Letter
Identification of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain FC428, China
Table
Strains | Year | Country (reference) | Sexual contact history | MIC, mg/L |
MLST | porB | tbpB | NG-MAST | penA | NG-STAR | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TET | SPT | CRO | CIP | AZI | CEF | ||||||||||
Japan-FC428 | 2015 | Japan (6) | NA | 0.5 | 8 | 0.5 | >32 | 0.25 | 1 | 1903 | 1053 | 21 | 3435 | 60 | 233 |
Japan-FC460 | 2015 | Japan (6) | NA | 0.5 | 8 | 0.5 | >32 | 0.25 | 1 | 1903 | 1053 | 21 | 3435 | 60 | 233 |
China-BJ16148 | 2016 Aug | China (this study) | China | 4 | 16 | 0.5 | >32 | 0.25 | 1 | 1903 | 1053 | 21 | 3435 | 60 | 233 |
Denmark-GK124 | 2017 Jan | Denmark (7) | Denmark, China, Australia | NA | 8 | 0.5 | >32 | 0.5 | 1 | 1903 | 1053 | 33 | 1614 | 60 | 233 |
Canada-47707 | 2017 Jan | Canada (8) | China, Thailand | 4 | 16 | 1 | >32 | 0.5 | 2 | 1903 | 1053 | 33 | 1614 | 60 | 233 |
Australia-A7846 | 2017 Apr | Australia (9) | Cambodia, Philippines | 2 | 8 | 0.5 | >32 | 0.25 | NA | 1903 | 1053 | 33 | 1614 | 60 | 233 |
Australia-A7536 | 2017 Aug | Australia (9) | China | 4 | 8 | 0.5 | >32 | 0.25 | NA | 1903 | 9300 | 21 | 15925 | 60 | 233 |
*AZI, azithromycin; CEF, cefixime; CIP, ciprofloxacin; CRO, ceftriaxone; MLST, multilocus sequence typing; NA, not available; NG-MAST, N. gonorrhoeae multiantigen sequence typing; NG-STAR, N. gonorrhoeae sequence typing for antimicrobial resistance; SPT, spectinomycin; TET, tetracycline.
References
- Yin YP, Han Y, Dai XQ, Zheng HP, Chen SC, Zhu BY, et al. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018;15:
e1002499 . DOIPubMedGoogle Scholar - Chen SC, Yin YP, Chen XS. Cephalosporin-resistant Neisseria gonorrhoeae clone, China. Emerg Infect Dis. 2018;24:804–6. DOIPubMedGoogle Scholar
- Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004;189:1497–505. DOIPubMedGoogle Scholar
- Jolley KA, Maiden MC. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010;11:595. DOIPubMedGoogle Scholar
- Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, et al. Neisseria gonorrhoeae sequence typing for antimicrobial resistance, a novel antimicrobial resistance multilocus typing scheme for tracking global dissemination of N. gonorrhoeae strains. J Clin Microbiol. 2017;55:1454–68. DOIPubMedGoogle Scholar
- Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M. New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016;60:4339–41. DOIPubMedGoogle Scholar
- Terkelsen D, Tolstrup J, Johnsen CH, Lund O, Larsen HK, Worning P, et al. Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Euro Surveill. 2017;22:22. DOIPubMedGoogle Scholar
- Lefebvre B, Martin I, Demczuk W, Deshaies L, Michaud S, Labbé AC, et al. Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017. Emerg Infect Dis. 2018;24:381–3. DOIPubMedGoogle Scholar
- Lahra MM, Martin I, Demczuk W, Jennison AV, Lee KI, Nakayama SI, et al. Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerg Infect Dis. 2018;24:735–40. DOIPubMedGoogle Scholar
- Wi T, Lahra MM, Ndowa F, Bala M, Dillon JR, Ramon-Pardo P, et al. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med. 2017;14:
e1002344 . DOIPubMedGoogle Scholar
Page created: March 22, 2019
Page updated: March 22, 2019
Page reviewed: March 22, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.